Targeting Wnt-driven metabolic adaptations in cancer: integrating glycolysis, glutaminolysis, IDO1-mediated immune evasion, and therapeutic delivery strategies.
Saved in:
| Title: | Targeting Wnt-driven metabolic adaptations in cancer: integrating glycolysis, glutaminolysis, IDO1-mediated immune evasion, and therapeutic delivery strategies. |
|---|---|
| Authors: | Flores-Hernández E; Departamento de Biología Celular, Facultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico., Binder G; Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States., Mei KC; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Binghamton, Binghamton, NY, United States.; Department of Molecular Pharmaceutics, College of Pharmacy, University of Utah, Salt Lake City, UT, United States., Tejeda-Muñoz N; Department of Oncology Science, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.; OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. |
| Source: | Frontiers in cell and developmental biology [Front Cell Dev Biol] 2025 Aug 22; Vol. 13, pp. 1622218. Date of Electronic Publication: 2025 Aug 22 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
